Header Logo

MICHAEL CURRAN

Concepts (357)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with MICHAEL CURRAN's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that MICHAEL CURRAN has written about over time.
Immunodeficiency Virus, Feline, 7 publications between 2000 and 2008, average publication date February 2003. Genetic Vectors, 11 publications between 2000 and 2012, average publication date May 2004. Cancer Vaccines, 5 publications between 2006 and 2018, average publication date September 2012. Antigens, Differentiation, 4 publications between 2006 and 2023, average publication date December 2012. Melanoma, Experimental, 11 publications between 2006 and 2020, average publication date August 2014. CTLA-4 Antigen, 11 publications between 2006 and 2019, average publication date February 2015. Tumor Necrosis Factor Receptor Superfamily, Member 9, 5 publications between 2011 and 2018, average publication date February 2015. Membrane Proteins, 7 publications between 2009 and 2022, average publication date August 2017. T-Lymphocytes, 13 publications between 2009 and 2023, average publication date January 2018. Programmed Cell Death 1 Receptor, 13 publications between 2010 and 2023, average publication date April 2018. Immunotherapy, 21 publications between 2006 and 2023, average publication date June 2018. Toll-Like Receptor 9, 2 publications between 2019 and 2019, average publication date June 2019. Nitroimidazoles, 3 publications between 2018 and 2021, average publication date July 2019. Phosphoramide Mustards, 3 publications between 2018 and 2021, average publication date July 2019. Neoplasms, 14 publications between 2011 and 2023, average publication date August 2019. Tumor Microenvironment, 20 publications between 2012 and 2024, average publication date October 2020. Infusions, Intraventricular, 1 publications between 2022 and 2022, average publication date February 2022. Myeloid-Derived Suppressor Cells, 2 publications between 2021 and 2024, average publication date October 2022. CD47 Antigen, 3 publications between 2022 and 2023, average publication date January 2023. Interferon Type I, 1 publications between 2024 and 2024, average publication date March 2024.

To see the data from this visualization as text, click here.
CURRAN's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (357)
Explore
_
Co-Authors (110)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_